What did Haemonetics Corp. pay for Cardiva Medical, Inc.?

Haemonetics Corp. acquired Cardiva Medical, Inc. for $442.3M in 2021, equivalent to 6.30x revenue. Target revenue was approximately $70.0M.

What does Cardiva Medical, Inc. do?

Cardiva Medical, Inc. is a medical devices business.

What multiple did Haemonetics Corp. pay for Cardiva Medical, Inc.?

6.30x revenue, based on disclosed deal value of $442.3M and disclosed financials.

M&A TRANSACTION · 2021

Cardiva Medical, Inc. acquired by Haemonetics Corp.

$442.3M· 6.30x revenue

Target

Cardiva Medical, Inc.

Acquirer

Haemonetics Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$70.0M

EBITDA

—

Deal Value

$442.3M

EV/EBITDA

—

Context

This $442.3M acquisition of Cardiva Medical, Inc. by Haemonetics Corp. sits in the medical devices sub-vertical. Haemonetics Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Cardiva Medical, Inc. acquisition.

Citation: ExitValue.ai. (2021). Cardiva Medical, Inc. acquired by Haemonetics Corp.. https://exitvalue.ai/deals/cardiva-medical-inc-acquired-by-haemonetics-corp-hc-2021-0109